Praziquantel (PZQ) is a drug of choice for treating schistosomiasis mansoni. Praziquantel was effectively used to treat schistosomiasis, but there are reports that indicate the appearance of Praziquantel resistance. The objective of this study was to determine the rate of S. mansoni infection before and after single treatment, thus to measure the efficacy of Praziquantel in treating Schistosoma mansoni infected individuals in the study area. The study utilized microscopic examination of two Kato-Katz slides for each individual sample before and after treatment. The cure rate of S. mansoni infection by Praziquantel in the two study areas remains high and with no significant difference. In Timuga cure rate was 93.44% and in Waja 88.99% (χ 2 = 3.644 and P= 0.16). Efficacy of Praziquantel in treating infections due to S. mansoni is still high and there is no evidence for resistance S. mansoni against Praziquantel in Tumuga and Waja.
INTRODUCTION
Globally, schistosomiasis is responsible for 500,000 deaths annually (Dupre et al., 1999) . The overall prevalence of S. mansoni infection in Ethiopia in 225 communities studied between 1979 -1982 was 14% (Ayele, 1982 .
As reduction of schistosomiasis is still beyond human and financial resources, the aim of most control programs remains the reduction of morbidity by treating infected people on an individual or population basis by using chemotherapy agents such as Praziquantel (WHO, 1993) . Praziquantel was effectively used to treat schistosomiasis since the last two decades (WHO, 1993; Magnussen, 2003) . The treatment of schistosomiasis by Praziquantel requires administration of a single dose 40mg/ kg of body weight (Engels et al., 2000) . As the drug is supplied by a reasonable price in hospitals, still now in Ethiopia, especially in the study area, Praziquantel is the drug of choice in treating schistosome infected individuals. Botros, 2004) . Interestingly, there is no report of resistance to multiple treatments by Praziquantel and oxamniquine (Follon and Doenhoff, 1994) .
The occurrence of Praziquantel resistant schistosomes is a potential problem to control schistosomiasis. Thus, such survey was designed to test whether there are Praziquantel resistant schistosomes in Tigray or not. In this study, determination of the rate of S. mansoni infection before and after single treatment was performed to measure the efficacy of Praziquantel in the treatment of S. mansoni infected individuals.
The outcome of the study will have important implications for schistosomiasis control.
Therefore, from the outcome of the study a clear recommendation in treatment of schistosomiasis will be given, that is by praziquantel alone or by mixed treatment with that of oxamniquine. But treating individuals by mixed treatment without having the information of resistance history costs unnecessary expense. The information that will be gained might provide baseline data for designing suitable and cost effective control scheme against schistosomiasis mansoni in our country. Besides, the study may be helpful to the understanding of the current status efficacy status of praziquantel in Ethiopia.
MATERIALS AND METHODS
The study was done in two towns in the southern tip of Tigray Regional State (northern Ethiopia); Timuga and Waja, 190km and 195km , respectively far to the south from the capital city of the region, Mekelle. The two cities were selected purposely based on previous schistosomiasis mansoni prevalence rate of 87% in Timuga (Tadesse and Beyene, 2009) and 36.4% in Waja (Tadesse et al., 2009) . In this study, schoolchildren were used to index the assessment of community prevalence (Guyatt et al., 1999) .
Sample size (n) was determined using the statistical formula p (1-p) z 2 / d 2 (Daniel, 1995) .
The overall prevalence rate (p) of S. mansoni in the study area was determined to be 61.7%
from the previous studies in the same study area; p was taken to be 61.7% (Tadesse et al.,
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Volume 2 (2): [3] [4] [5] [6] [7] [8] [9] [10] [11] 2010 © CNCS Mekelle University 5 2009; Tadesse and Beyene 2009). For the calculation, a 95% confidence interval (z) and a 5% margin of error (d) were used. This gave a sample size of 364. Besides, to minimize errors arising from the likelihood of non compliance, seven percent of the sample size was added to the normal sample (364 + 26= 390). Thus, a total of 390 schoolchildren (152 females and 238 males) were selected from Waja (172) and Tumuga (218) Primary schools. The subjects were selected randomly from their grade categories. The study utilized examination of Kato-Katz slides (42.7 mg stool/slide) for each individual (Peters et al., 1980) . Four weeks after the first treatment, the treated patients were tested again, using two Kato-Katz slides for each The data collected was entered in to SPSS program version 12 and were analyzed by using appropriate statistical packages (percentile and Chi-square test).
RESULTS AND DISCUSSION

Prevalence of S. mansoni
The prevalence of Schistosoma mansoni in both study areas Tumuga and Waja was 63.3% and 73.84%, respectively (Table 1 ). The average prevalence of schistosomiasis mansoni in both study areas was 67.95%. This average is done because the old town Waja on the south direction and the new town Tumuga on the north direction are divided by A Waja Wuha River. When compared with previous studies in Tumuga (Author, 2009) 
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Pretreatment Results
Similar proportion of the age dependent prevalence of S. mansoni infection was demonstrated in both before and after infection (Fig. 1) . The highly affected age groups were 10-14 and 15-19 year old and the least affected age groups were 5-9 and 20-24 (χ 2 =12.3, P< 0.05). Similar findings were reported in the same study sites and elsewhere in Ethiopia (Berhanu, 1988; Hailu et al., 1997; Alemayehu et al., 1998; Tadesse and Beyene, 2009) 
Post treatment results
The cure rate after one treatment with the standard dose of 40 mg/kg PZQ was 84.5%, ranging from 73.8 to 92.3% in the individual primary schools (Table 2) . Infection before and after treatment was highly significant (Fig. 2 ) (χ 2 = 15. 66 and P= 0.000) but cure rate among sexes remains in similar proportion (p>0.05). The results of the present study indicated that there is no sex difference in S. mansoni infection in both pre-and post-treatment tests. This findings agree with previous works by the same authors in the study sites (Tadesse and Tadesse, D., Tsehaye, A and Mahmud, A (MEJS) Volume 2 (2): [3] [4] [5] [6] [7] [8] [9] [10] [11] 2010 © CNCS Mekelle University 7 Beyene, 2009) Such findings indicate that there is no S. mansoni infection difference between male and female sexes, and also confirmed the efficacy of PZQ has no sex bias. 
